Burkina Faso vs Macao: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Macao
100.0%
in 2024
Burkina Faso rank
1st
Macao rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Macao
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Macao, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Macao ahead.
Burkina Faso ranks 1st and Macao ranks 1st of 144 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Macao in 1.
Head to head by decade
| Decade | Burkina Faso | Macao | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.5% | 68.8% | 26.2% | Macao |
| 2010s | 79.1% | 65.3% | 13.8% | Burkina Faso |
| 2020s | 94.2% | 78.4% | 15.8% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Macao?
- Burkina Faso, at 100.0% against 100.0% in Macao as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Macao?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Macao?
- 18 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Macao rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Macao ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.